Trial Profile
A study to evaluate the Pharmacokinetics and Pharmacodynamics of tolvaptan in congestive heart failure patients with renal impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Pharmacokinetics
- 08 Jun 2013 Status changed from not stated to completed as reported by University Hospital Medical Information Network - Japan record.
- 09 Dec 2011 New trial record